Signant Health, an evidence generation company, has joined IQVIA's One Home for Sites initiative to expand the availability of its eClinical solutions.

The partnership allows Signant's SmartSignals Unified Platform to be accessible through IQVIA's One Home for Sites, a collaborative platform designed for research staff to simplify clinical trial conduct using multiple eClinical technologies. This integration aims to streamline access to various trial technologies from different providers through a single sign-on system, improving efficiency for clinical research sites.

The collaboration aligns with Signant's product strategy of providing unified access to its products through the Signant SmartSignals ID Portal and supports IQVIA's goal of creating a consolidated ecosystem for easier site access to multiple solution providers in clinical trials.

Analyst QuickTake: This marks the second partnership IQVIA established this year. Earlier, in April 2024 , IQVIA expanded its partnership with Salesforce, a global cloud computing company, to accelerate the development of Salesforce’s Life Sciences Cloud, a customer engagement platform for the global life sciences sector.